GlassScriptPhysician profile
Katie Lovett
NPI 1033881446
$4,452.88
in general payments reported to CMS, 2019-2025
30 companies · $731 in 2025
The $731 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $909 · 2023: $1,573 · 2024: $1,240 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,544.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $916.71 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $802.58 | 2022-2025 | Xtampza, Belbuca |
| Protega Pharmaceutials INC | $703.47 | 2023-2025 | Roxybond |
| Scilex Pharmaceuticals INC. | $399.19 | 2022-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $295.93 | 2023-2025 | Relistor |
| Biohaven Pharmaceutical Holding Company LTD. | $180.47 | 2022 | |
| Electronic Waveform Lab, INC. | $149.06 | 2023-2024 | |
| Averitas Pharma INC. | $114.57 | 2023-2024 | Qutenza |
| Biotronik Nro, INC. | $92.41 | 2023-2025 | Prospera, Biotronik |
| Vertos Medical, INC. | $87.18 | 2023-2024 | Mild Device Kit |
| Grt US Holding, INC. | $78.62 | 2022 | |
| Curonix LLC | $74.72 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mml US, INC. | $63.11 | 2025 | Reactiv8 |
| Almatica Pharma LLC | $52.45 | 2022 | |
| Mallinckrodt Hospital Products INC. | $50.74 | 2024 | Acthar |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $50.60 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $47.77 | 2022-2024 | Exparel, Iovera, Zilretta |
| Pfizer INC. | $34.36 | 2023 | |
| Nevro Corp. | $31.80 | 2022 | |
| International Rehabilitative Sciences, INC | $26.96 | 2024 | Rs 4i Plus Sequential Stimulator |
| Stimwave Technologies Incorporated | $26.08 | 2022 | |
| Abbott Laboratories | $23.95 | 2025 | Proclaim |
| Globus Medical, INC. | $23.03 | 2025 | Senza |
| Amgen INC. | $22.12 | 2025 | Krystexxa |
| Depuy Synthes Sales INC. | $21.10 | 2022 | |
| Valinor Pharma, LLC | $20.96 | 2025 | Movantik |
| Redhill Biopharma INC. | $17.73 | 2022 | |
| Si-Bone, INC. | $15.79 | 2022 | |
| Medtronic, INC. | $15.17 | 2025 | Inceptiv |
| Ultragenyx Pharmaceutical INC. | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Lovett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.